ARBUTUS BIOPHARMA CORP
ABUS·03879J100·US·Common Stock·Healthcare - Biotechnology-Activist
ABUS institutional ownership changes in Q2 2026: 64 institutions opened or added positions, 41 trimmed or exited. ABUS (ARBUTUS BIOPHARMA CORP) is held by 107 institutional investors as of Q2 2026. Top institutional shareholders: MORGAN STANLEY ($85M), BlackRock, Inc. ($66.1M), STATE STREET CORP ($37.8M). Net institutional sentiment: Mixed.
Who's Trading
Source dates: Price Oct 23, 2026 · Insiders Oct 7, 2026 · Activists Oct 7, 2026 · Congress none
Top Holders
Showing 1-20 of 122
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer